Physician

Christopher E Avendano, M.D.

According to 2025 Medicare claims, Christopher Avendano, M.D. (NPI: 1003868126) practices pulmonary disease in the Sandusky, OH market, with the plurality of this provider's patient population coming from Erie, OH. This provider's primary affiliated billing organization is NORTH COAST PROFESSIONAL COMPANY, LLC (NPI: 1881648210; TIN: 341608091) and primary practice location at 44870-3323. Avendano is affiliated with the Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Avendano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 2,847 HCPCS/CPT codes, and received $159,628 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 2,032 prescription claims across 354 beneficiaries totaling $1,256,629 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,056 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $145,126 and ending at $159,628. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $443,065 to $1,256,629. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $123,313 and ending at $118,467.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	822	2,351	$145,126
2016	1,120	3,393	$204,729
2017	1,046	3,143	$182,076
2018	999	2,872	$166,219
2019	932	2,640	$157,227
2020	888	2,569	$154,445
2021	834	2,424	$137,959
2022	714	2,030	$94,887
2023	671	1,822	$97,084
2024	735	2,847	$159,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	1,809	$443,065
2016	348	2,119	$580,219
2017	328	2,003	$552,737
2018	368	2,254	$873,461
2019	371	2,492	$1,034,251
2020	399	2,482	$1,071,861
2021	398	2,837	$1,534,749
2022	369	2,407	$1,347,945
2023	352	2,196	$1,432,127
2024	354	2,032	$1,256,629

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	694	2,117	$131,706
2016	1,068	2,974	$122,477
2017	1,086	2,886	$99,230
2018	840	2,291	$99,342
2019	949	2,411	$112,317
2020	862	2,303	$111,091
2021	872	2,238	$106,375
2022	837	2,300	$144,792
2023	757	2,307	$167,373
2024	760	2,056	$119,144

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	203	241	$100
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	216	872	$60
94726	Test to determine lung volumes using sensors	241	276	$9
94060	Test to measure expiratory airflow and volume changes before and after medication administration	177	185	$8
94729	Test to examine how well the lungs exchange gases	259	297	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	313	15,480	$321,092
Uptravi	Selexipag	12	360	$279,273
Breo Ellipta	Fluticasone/Vilanterol	120	6,060	$78,167
Spiriva Respimat	Tiotropium Bromide	73	3,570	$63,184
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	43	2,310	$33,585

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	32	272	$22,190
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	13	$13,086
E0465	Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)	Y	N/R	12	$12,253
A7031	Face mask interface, replacement for full face mask, each	N	52	103	$8,733
A7030	Full face mask used with positive airway pressure device, each	N	54	96	$8,006

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Christopher E. Avendano, M.D.?

Tedicare shows public-source Medicare data for Christopher E. Avendano, M.D. (NPI 1003868126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher E. Avendano, M.D. have ACO affiliation data?

Christopher E. Avendano, M.D. is shown with ACO affiliation data for Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Christopher E. Avendano, M.D.?

Christopher E. Avendano, M.D. is linked to NORTH COAST PROFESSIONAL COMPANY, LLC (billing NPI 1881648210) in the available physician profile data.

Does Christopher E. Avendano, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.